Literature DB >> 11821041

Potent transforming activity of the small GTP-binding protein Rit in NIH 3T3 cells: evidence for a role of a p38gamma-dependent signaling pathway.

Kaoru Sakabe1, Hidemi Teramoto, Muriel Zohar, Babak Behbahani, Hiroshi Miyazaki, Hiroki Chikumi, J Silvio Gutkind.   

Abstract

A novel branch of the Ras family, Rit, was recently identified. Rit exhibits a distinct C-terminus and effector domain, and does not activate mitogen-activated protein kinase (MAPK) but can cooperate with Raf to transform fibroblasts. Here, we found that when overexpressed, activated mutants of Rit transform NIH 3T3 cells efficiently, and stimulate p38gamma but not MAPK, p38alpha, p38gamma, p38delta, or ERK5. Furthermore, we provide evidence that p38gamma activation is required for the ability of Rit to stimulate gene expression and cellular transformation. These findings suggest that this unique GTPase stimulates proliferative pathways distinct from those regulated by other Ras family members.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11821041     DOI: 10.1016/s0014-5793(01)03264-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  Spectrum of mutations and genotype-phenotype analysis in Noonan syndrome patients with RIT1 mutations.

Authors:  Masako Yaoita; Tetsuya Niihori; Seiji Mizuno; Nobuhiko Okamoto; Shion Hayashi; Atsushi Watanabe; Masato Yokozawa; Hiroshi Suzumura; Akihiko Nakahara; Yusuke Nakano; Tatsunori Hokosaki; Ayumi Ohmori; Hirofumi Sawada; Ohsuke Migita; Aya Mima; Pablo Lapunzina; Fernando Santos-Simarro; Sixto García-Miñaúr; Tsutomu Ogata; Hiroshi Kawame; Kenji Kurosawa; Hirofumi Ohashi; Shin-Ichi Inoue; Yoichi Matsubara; Shigeo Kure; Yoko Aoki
Journal:  Hum Genet       Date:  2015-12-29       Impact factor: 4.132

2.  Biochemical Classification of Disease-associated Mutants of RAS-like Protein Expressed in Many Tissues (RIT1).

Authors:  Zhenhao Fang; Christopher B Marshall; Jiani C Yin; Mohammad T Mazhab-Jafari; Geneviève M C Gasmi-Seabrook; Matthew J Smith; Tadateru Nishikawa; Yang Xu; Benjamin G Neel; Mitsuhiko Ikura
Journal:  J Biol Chem       Date:  2016-05-18       Impact factor: 5.157

3.  p38γ mitogen-activated protein kinase contributes to oncogenic properties maintenance and resistance to poly (ADP-ribose)-polymerase-1 inhibition in breast cancer.

Authors:  Fanyan Meng; Haijun Zhang; Gang Liu; Bas Kreike; Wei Chen; Seema Sethi; Fred R Miller; Guojun Wu
Journal:  Neoplasia       Date:  2011-05       Impact factor: 5.715

4.  Rit contributes to nerve growth factor-induced neuronal differentiation via activation of B-Raf-extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades.

Authors:  Geng-Xian Shi; Douglas A Andres
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

Review 5.  Rit subfamily small GTPases: regulators in neuronal differentiation and survival.

Authors:  Geng-Xian Shi; Weikang Cai; Douglas A Andres
Journal:  Cell Signal       Date:  2013-06-11       Impact factor: 4.315

6.  Rit mutants confirm role of MEK/ERK signaling in neuronal differentiation and reveal novel Par6 interaction.

Authors:  Jennifer L Rudolph; Geng-Xian Shi; Eda Erdogan; Alan P Fields; Douglas A Andres
Journal:  Biochim Biophys Acta       Date:  2007-10-09

7.  The molecular functions of RIT1 and its contribution to human disease.

Authors:  Richard Van; Antonio Cuevas-Navarro; Pau Castel; Frank McCormick
Journal:  Biochem J       Date:  2020-08-14       Impact factor: 3.857

8.  Rit GTPase regulates a p38 MAPK-dependent neuronal survival pathway.

Authors:  Weikang Cai; Jennifer L Rudolph; Tomoko Sengoku; Douglas A Andres
Journal:  Neurosci Lett       Date:  2012-11-02       Impact factor: 3.046

Review 9.  Human RAS superfamily proteins and related GTPases.

Authors:  John Colicelli
Journal:  Sci STKE       Date:  2004-09-07

Review 10.  Recent advances in RASopathies.

Authors:  Yoko Aoki; Tetsuya Niihori; Shin-ichi Inoue; Yoichi Matsubara
Journal:  J Hum Genet       Date:  2015-10-08       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.